Pharmaceutical companies must ensure the free provision of treatments to patients after the completion of clinical trials, as stipulated in a new regulation that governs this obligation until the introduction of the drugs in the market and their access by the National Health Service. #EnsaiosClinicos #Medicina #Saude (translated)


